Skip to main content

Advertisement

Log in

Increased spontaneous, tumor necrosis factor receptor- and CD95 (Fas)-mediated apoptosis in cord blood T-cell subsets from Turner's syndrome

  • Brief Communication
  • Published:
Genes & Immunity Submit manuscript

Abstract

Increased spontaneous as well as TNF-α-induced and CD95-mediated apoptosis were observed in CD4+ and CD8+ T cells from the cord blood of a patient with Turner's syndrome as compared to normal cord blood. Increased apoptosis was associated with an increased expression of TNFR-1, TNFR-2, and CD95L and decreased expression of cIAP1 and FLIPL. No significant difference was observed in the expression of Bcl-2 family members (Bcl-2, Bax) between Turner's syndrome cord blood and normal cord blood lymphocytes. This study demonstrates that increased apoptosis of T-cell subsets in Turner's syndrome occurs via the death receptor pathway and may play a role in the pathogenesis of immunological defects associated with Turner's syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. Hengartner MO . The biochemistry of apoptosis. Nature 2000; 407: 770–776.

    Article  CAS  Google Scholar 

  2. Krammer PH . CD95's deadly mission in the immune system. Nature 2000; 407: 789–795.

    Article  CAS  Google Scholar 

  3. Gupta S . Decision between life and death during TNF-α-induced signaling. J Clin Immunol 2002; 22: 185–194.

    Article  CAS  Google Scholar 

  4. Ashkanazi A, Dixit VM . Death receptors: signaling and modulation. Science 1998; 281: 1305–1308.

    Article  Google Scholar 

  5. Gupta S . Molecular steps of TNF receptor-mediated apoptosis. Curr Mol Med 2001; 1: 299–306.

    Article  Google Scholar 

  6. Gupta S . Molecular steps of death receptor and mitocondrial pathways of apoptosis. Life Sci 2001; 69: 2957–2964.

    Article  CAS  Google Scholar 

  7. Kroemer G, Reed JC . Mitochondrial control of cell death. Nat Med 2000; 6: 513–519.

    Article  CAS  Google Scholar 

  8. Green DR, Evans GI . A matter of life and death. Cancer Cell 2002; 1: 19–30.

    Article  CAS  Google Scholar 

  9. Jensen K, Petersen PH, Nielsen LE, Dahl G, Nielsen J . Serum immunoglobulin M, and A concentration levels in Turner's syndrome compared with normal women and men. Hum Gen 1976; 31: 329–334.

    Article  CAS  Google Scholar 

  10. Lorini R, Ugazio AG, Cammareri V et al. Immunoglobulin levels, T-cell markers, mitogens responsiveness and thymic hormone activity in Turner's syndrome. Thymus 1983; 5: 61–66.

    CAS  PubMed  Google Scholar 

  11. Cacciari E, Masi M, Fantini MP et al. Serum immunoglobulins and lymphocyte subpopulation derangement in Turner's syndrome. J Immunogenet 1981; 8: 337–344.

    Article  CAS  Google Scholar 

  12. Al-Attas RA, Rahi AHS, Ahmed EL Fe . Common variable immunodeficiency with CD4+ T lymphopenia and over production of IL-2 receptor associated with Turner's syndrome and dorsal kyphoscoliosis. J Clin Pathol 1997; 50: 876–879.

    Article  CAS  Google Scholar 

  13. Robson SC, Potter PC . Common variable immunodeficiency associated with Turner's syndrome. J Clin Lab Immunol 1990; 32: 337–344.

    Google Scholar 

  14. Hochberg Z, Aviram M, Rubin D, Pollack S . Decreased sensitivity of insulin-like growth factor I in Turner's syndrome: a study of monocytes and T lymphocytes. Eur J Clin Invest 1997; 27: 543–547.

    Article  CAS  Google Scholar 

  15. Kurabayashi T, Yasuda M, Fujimaki T, Yamamoto Y, Oda K, Tanaka K . Effect of hormone replacement therapy on spinal cord bone density and T lymphocyte subsets in premature ovarian failure and Turner's syndrome. Int J Gynaecol Obstet 1993; 42: 25–31.

    Article  CAS  Google Scholar 

  16. Mock MUR, Vogelsang H, Jager L . Selective T cell deficiency in Turner's syndrome. J Invest Allerg Clin Immunol 2000; 5: 312–313.

    Google Scholar 

  17. Shewior S, Brand M, Santer R . Celiac disease and selective IgA deficiency in a girl with atypical Turner's syndrome. J Ped Gastroent Nutr 1999; 28: 353–354.

    Article  Google Scholar 

  18. Gupta S, Aggarwal S, Nguyen T . Increased spontaneous apoptosis of T lymphocytes in DiGeorge anomaly. Clin Exp Immunol 1998; 113: 65–71.

    Article  CAS  Google Scholar 

  19. Schubert R, Reichenbach J, Royer N, Pichler M, Zielen S . Spontaneous and oxidative stress-induced programmed cell death in lymphocytes from patients with ataxia telangiectasia. Clin Exp Immunol 2000; 119: 140–170.

    Article  CAS  Google Scholar 

  20. Yel L, Aggarwal S, Gupta S . Cartilage-hair hypoplasia syndrome: increased apoptosis of T lymphocytes is associated with altered expression of Fas (CD95), FasL (CD95L), IAP, Bax and Bcl-2. J Clin Immunol 1999; 19: 428–435.

    Article  CAS  Google Scholar 

  21. Suda T, Okazaki T, Naito Y et al. Expression of the Fas ligand in the cells of T cell lineage. J Immunol 1995; 154: 3806–3813.

    CAS  Google Scholar 

  22. Thome M, Schneider P, Hofmann C et al. Viral flice-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 1997; 386: 517–521.

    Article  CAS  Google Scholar 

  23. Imler M, Thome M, Hahne M et al. Inhibition of death receptor signals by cellular FLIP. Nature 1997; 388: 190–195.

    Article  Google Scholar 

  24. Kataoka T, Budd RC, Holler N et al. The caspases-8 inhibitor FLIP promotes activation of NF-kB and Erk signaling pathways. Curr Biol 2000; 10: 640–648.

    Article  CAS  Google Scholar 

  25. Gupta S . Molecular signaling in death receptor and mito-chondrial Pathways o f apoptosis. Internet. J. Oncology (in press).

  26. Pimentel-Muinos FX, Seed B . Regulated commitment of TNF receptor signaling: a molecular switch for death or activation. Immunity 1999; 11:783–793.

    Article  CAS  Google Scholar 

  27. Weiss T, Grell M, Siekienski K et al. TNFR80-dependent enhancement of TNFR60-induced cell death is mediated by TNFR-associated factor 2 and is specific for TNFR60. J Immunol 1998; 161:3136–3142.

    CAS  PubMed  Google Scholar 

  28. Hu S, Vincenz C, Ni J, Genz R, Dixit VM . I-Flice, a novel inhibitor of tumor necrosis factor receptor-1 and CD95-induced apoptosis. J Biol Chem 1997; 272: 17255–17257.

    Article  CAS  Google Scholar 

  29. Deveraux QL, Stennicke HR, Salvesen GS, Reed JC . Endogenous inhibitors of caspases. J Clin Immunol 1999; 19: 350–364.

    Article  Google Scholar 

  30. Salvesen GS, Duckett CS . IAP proteins: blocking the road to death door. Nat Rev Mol Cell Biol 2002; 3: 401–410.

    Article  CAS  Google Scholar 

  31. Scaffidi C, Fulda S, Srinivasan A et al. Two CD95 (Apo-1/Fas) signaling pathways. EMBO J 1998; 17: 1675–1687.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S Gupta.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gupta, S., Chiplunkar, S., Gupta, A. et al. Increased spontaneous, tumor necrosis factor receptor- and CD95 (Fas)-mediated apoptosis in cord blood T-cell subsets from Turner's syndrome. Genes Immun 4, 239–243 (2003). https://doi.org/10.1038/sj.gene.6363945

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gene.6363945

  • Springer Nature Limited

Keywords

This article is cited by

Navigation